Merck Loses Rehearing Bid In 3rd Circ. Fosamax Warning Suit
The Third Circuit on Monday declined to reconsider its decision to revive claims in multidistrict litigation against Merck over an alleged failure to warn patients about the risk of irregular hip fractures...To view the full article, register now.
Already a subscriber? Click here to view full article